These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
230 related items for PubMed ID: 1373633
1. [Clinical biochemical and genetic aspects of peroxisome-deficient disorders]. Suzuki Y. No To Hattatsu; 1992 Mar; 24(2):194-7. PubMed ID: 1373633 [Abstract] [Full Text] [Related]
2. Identification of three distinct peroxisomal protein import defects in patients with peroxisome biogenesis disorders. Slawecki ML, Dodt G, Steinberg S, Moser AB, Moser HW, Gould SJ. J Cell Sci; 1995 May; 108 ( Pt 5)():1817-29. PubMed ID: 7544797 [Abstract] [Full Text] [Related]
3. Pseudo infantile Refsum's disease: catalase-deficient peroxisomal particles with partial deficiency of plasmalogen synthesis and oxidation of fatty acids. Aubourg P, Kremser K, Roland MO, Rocchiccioli F, Singh I. Pediatr Res; 1993 Sep; 34(3):270-6. PubMed ID: 7510868 [Abstract] [Full Text] [Related]
4. Genetic and phenotypic heterogeneity in disorders of peroxisome biogenesis--a complementation study involving cell lines from 19 patients. Roscher AA, Hoefler S, Hoefler G, Paschke E, Paltauf F, Moser A, Moser H. Pediatr Res; 1989 Jul; 26(1):67-72. PubMed ID: 2475849 [Abstract] [Full Text] [Related]
5. Peroxisomal disorders. Neurodevelopmental and biochemical aspects. Brown FR, Voigt R, Singh AK, Singh I. Am J Dis Child; 1993 Jun; 147(6):617-26. PubMed ID: 7685145 [Abstract] [Full Text] [Related]
7. Peroxisomal integral membrane proteins in livers of patients with Zellweger syndrome, infantile Refsum's disease and X-linked adrenoleukodystrophy. Small GM, Santos MJ, Imanaka T, Poulos A, Danks DM, Moser HW, Lazarow PB. J Inherit Metab Dis; 1988 Jun; 11(4):358-71. PubMed ID: 2468817 [Abstract] [Full Text] [Related]
8. Molecular analysis of peroxisomal beta-oxidation enzymes in infants with peroxisomal disorders indicates heterogeneity of the primary defect. Guerroui S, Aubourg P, Chen WW, Hashimoto T, Scotto J. Biochem Biophys Res Commun; 1989 May 30; 161(1):242-51. PubMed ID: 2471528 [Abstract] [Full Text] [Related]
9. [Clinical and molecular aspects of peroxisome-deficient disorders]. Suzuki Y, Shimozawa N, Orii T. Nihon Rinsho; 1993 Sep 30; 51(9):2353-8. PubMed ID: 7692118 [Abstract] [Full Text] [Related]
10. The deficient degradation of synthetic 2- and 3-methyl-branched fatty acids in fibroblasts from patients with peroxisomal disorders. Van Veldhoven PP, Huang S, Eyssen HJ, Mannaerts GP. J Inherit Metab Dis; 1993 Sep 30; 16(2):381-91. PubMed ID: 7692128 [Abstract] [Full Text] [Related]
11. Complementation study of peroxisome-deficient disorders by immunofluorescence staining and characterization of fused cells. Yajima S, Suzuki Y, Shimozawa N, Yamaguchi S, Orii T, Fujiki Y, Osumi T, Hashimoto T, Moser HW. Hum Genet; 1992 Mar 30; 88(5):491-9. PubMed ID: 1372585 [Abstract] [Full Text] [Related]
12. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers]. Molzer B, Stöckler S, Bernheimer H. Wien Klin Wochenschr; 1992 Mar 30; 104(21):665-70. PubMed ID: 1282286 [Abstract] [Full Text] [Related]
13. Phytanic acid and very long chain fatty acids in genetic peroxisomal disorders. Molzer B, Kainz-Korschinsky M, Sundt-Heller R, Bernheimer H. J Clin Chem Clin Biochem; 1989 May 30; 27(5):309-14. PubMed ID: 2474624 [Abstract] [Full Text] [Related]
14. Peroxisomal very long-chain fatty acid beta-oxidation in human skin fibroblasts: activity in Zellweger syndrome and other peroxisomal disorders. Wanders RJ, van Roermund CW, van Wijland MJ, Heikoop J, Schutgens RB, Schram AW, Tager JM, van den Bosch H, Poll-Thé BT, Saudubray JM. Clin Chim Acta; 1987 Jul 15; 166(2-3):255-63. PubMed ID: 2441904 [Abstract] [Full Text] [Related]
15. [Human peroxisome-deficient disorders and pathogenic gene]. Fujiki Y. Rinsho Shinkeigaku; 1994 Dec 15; 34(12):1219-21. PubMed ID: 7539728 [Abstract] [Full Text] [Related]
16. Standardization of complementation grouping of peroxisome-deficient disorders and the second Zellweger patient with peroxisomal assembly factor-1 (PAF-1) defect. Shimozawa N, Suzuki Y, Orii T, Moser A, Moser HW, Wanders RJ. Am J Hum Genet; 1993 Apr 15; 52(4):843-4. PubMed ID: 7681622 [No Abstract] [Full Text] [Related]